26358 Federal Register / Vol. 87, No. 86 / Wednesday, May 4, 2022 / Notices 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–09538 Filed 5–3–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Appointment to CDC’s Advisory 

Committee to the Director (ACD) 

Laboratory Workgroup (LW) 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), within 

the Department of Health and Human 

Services (HHS), is seeking nominations 

for membership on the Advisory 

Committee to the Director (ACD) 

Laboratory Workgroup (LW). The LW 

will consist of up to 15 members who 

are experts in the fields of public health 

laboratory science and practice, 

laboratory quality management, 

diagnostic regulations, and laboratory 

testing and research. 

DATES: Nominations for membership on 

the LW workgroup must be received no 

later than May 16, 2022. Late 

nominations will not be considered for 

membership. 

ADDRESSES: All nominations (cover 

letters and curriculum vitae) should be 

emailed to LWACD@cdc.gov with the 

subject line: ‘‘Nomination for CDC ACD 

LW Workgroup.’’ 

FOR FURTHER INFORMATION CONTACT: 

Lauren Hoffmann, MA, Office of the 

Chief of Staff, Centers for Disease 

Control and Prevention, 1600 Clifton 

Road NE, Mailstop H21–10, Atlanta, 

Georgia 30329–4027; Telephone: (404) 

639–7000; Email: LWACD@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The purpose of the ACD, 

CDC is to advise the Secretary, HHS, 

and the Director, CDC, on policy and 

broad strategies that will enable CDC to 

fulfill its mission of protecting health 

through health promotion, prevention, 

and preparedness. The ACD, CDC 

consists of up to 15 non-federal 

members, including the Chair, 

knowledgeable in areas pertinent to the 

CDC mission, such as health policy, 

public health, global health, 

preparedness, preventive medicine, the 

faith-based and community-based 

sector, and allied fields. 

Purpose: The establishment and 

formation of the LW is to provide input 

to the ACD, CDC on agency-wide 

activities related to laboratory quality 

management, continuous laboratory 

quality improvement, and laboratory 

diagnostic testing to support public 

health programs and investigations. The 

LW membership will consist of up to 15 

members. It will be co-chaired by two 

current ACD, CDC Special Government 

Employees. The LW co-chairs will 

present their findings, observations, and 

work products at one or more ACD, CDC 

meetings for discussion, deliberation, 

and decisions (final recommendations 

to CDC). 

Nomination Criteria: LW members 

will serve terms ranging from six 

months to one year and be required to 

attend LW meetings approximately 1–2 

times per month (virtually or in person), 

and contribute time between meetings 

for research, consultation, discussion, 

and writing assignments. 

Nominations are being sought for 

individuals who have the expertise and 

qualifications necessary to contribute to 

the accomplishments of the 

committee’s/workgroup’s objectives. 

Nominees will be selected based on 

expertise in the fields of public health 

laboratory science and practice, 

laboratory quality management, 

diagnostic regulations, and clinical 

laboratory testing and research. To 

ensure a diverse workgroup 

composition, nominees with front line 

and field experience at the local, state, 

tribal, and territorial levels are 

encouraged to apply. Federal employees 

will not be considered for membership. 

Selection of members is based on 

candidates’ qualifications to contribute 

to the accomplishment of the LW’s 

objectives. 

HHS policy stipulates that 

membership be balanced in terms of 

points of view represented and the 

workgroup’s function. Appointments 

shall be made without discrimination 

based on age, race, ethnicity, gender, 

sexual orientation, gender identity, HIV 

status, disability, and cultural, religious, 

or socioeconomic status. Nominees 

must be U.S. citizens and cannot be fulltime employees of the U.S. Government. 

Current participation on federal 

workgroups or prior experience serving 

on a federal advisory committee does 

not disqualify a candidate; however, 

HHS policy is to avoid excessive 

individual service on advisory 

committees and multiple committee 

memberships. 

Interested candidates should submit 

the following items: 

D A one-half to one-page cover letter 

that includes your understanding of, 

and commitment to, the time and work 

necessary; one to two sentences on your 

background and experience; and one to 

two sentences on the skills/perspective 

you would bring to the LW. 

D Current curriculum vitae which 

highlights the experience and work 

history being sought relevant to the 

criteria set forth above, including 

complete contact information 

(telephone numbers, mailing address, 

email address). 

Nominations may be submitted by the 

candidate him or herself, or by the 

person/organization recommending the 

candidate. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–09537 Filed 5–3–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier CMS–10398 #59] 

Medicaid and Children’s Health 

Insurance Program (CHIP) Generic 

Information Collection Activities: 

Proposed Collection; Comment 

Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: On May 28, 2010, the Office 

of Management and Budget (OMB) 

issued Paperwork Reduction Act (PRA) 

guidance related to the ‘‘generic’’ 

clearance process. Generally, this is an 

expedited process by which agencies 

may obtain OMB’s approval of 

collection of information requests that 

are ‘‘usually voluntary, low-burden, and 

uncontroversial collections,’’ do not 

raise any substantive or policy issues, 

and do not require policy or 

methodological review. The process 

requires the submission of an 


khammond on DSKJM1Z7X2PROD with NOTICES